Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000881228 | SCV001024386 | likely benign | Beckwith-Wiedemann syndrome | 2024-09-27 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004028303 | SCV004921133 | uncertain significance | Inborn genetic diseases | 2024-01-03 | criteria provided, single submitter | clinical testing | The c.471_482del12 (p.A161_P164del) alteration is located in exon 1 (coding exon 1) of the CDKN1C gene. This alteration consists of an in-frame deletion of 12 nucleotides between nucleotide positions c.471 and c.482, resulting in the deletion of 4 residues. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005047141 | SCV005676020 | uncertain significance | Beckwith-Wiedemann syndrome; IMAGe syndrome | 2024-05-06 | criteria provided, single submitter | clinical testing |